Skip to main content
. 2021 Oct 23;41(2):107–116. doi: 10.4103/ayu.ayu_14_21

Table 3.

Baseline characteristics of the participants in both the groups

Variables Parameters IG (n=25) CG (n=27) P $
Age:Mean±SD 43.68±9.97 35.22±11.80 0.448
Gender Male 18 (72.0) 18 (66.7) 0.677
Female 7 (28.0) 9 (33.3)
Clinical features Asymptomatic 9 (36.0) 8 (29.6) 0.625
Symptomatic 16 (64.0) 19 (70.4)
Stage of disease Group A 8 (32.0) 8 (29.6) 0.530
Group B 14 (56.0) 14 (51.9)
Group C 3 (12.0) 5 (18.5)
Comorbidities COPD 1 (4.0) 0 -
Bronchial asthma 2 (8.0) 2 (7.4) 0.936
Diabetes mellitus 3 (12.0) 2 (7.4) 0.575
Hypertension 2 (8.0) 5 (18.5) 0.267
Cardiovascular disease 0 2 (7.4) -
Thyroid dysfunction 0 3 (11.1) -
Bowel habits Regular 22 (88.0) 22 (81.5) 0.515
Irregular 3 (12.0) 5 (18.5)
Appetite Normal 23 (92.0) 23 (85.2) 0.442
Disturbed 2 (8.0) 4 (14.8)
Stool consistency Normal 22 (88.0) 20 (74.1) 0.203
Constipated 3 (12.0) 7 (25.9)

$Compared using Chi-square/Fisher’s exact test. Values have been expressed as n (%) for all variables except age. IG: Intervention group, CG: Control group, SD: Standard deviation, COPD: Chronic obstructive pulmonary disease